Does RIVASTIGMINE Cause Salivary hypersecretion? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Salivary hypersecretion have been filed in association with RIVASTIGMINE (Exelon). This represents 0.6% of all adverse event reports for RIVASTIGMINE.
51
Reports of Salivary hypersecretion with RIVASTIGMINE
0.6%
of all RIVASTIGMINE reports
4
Deaths
19
Hospitalizations
How Dangerous Is Salivary hypersecretion From RIVASTIGMINE?
Of the 51 reports, 4 (7.8%) resulted in death, 19 (37.3%) required hospitalization, and 6 (11.8%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for RIVASTIGMINE.
What Other Side Effects Does RIVASTIGMINE Cause?
Death (1,229)
Fall (587)
Malaise (514)
Drug ineffective (510)
Product adhesion issue (478)
Vomiting (432)
Dementia alzheimer's type (428)
Memory impairment (385)
Nausea (383)
Pneumonia (378)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which RIVASTIGMINE Alternatives Have Lower Salivary hypersecretion Risk?
RIVASTIGMINE vs RIVOTRIL
RIVASTIGMINE vs RIZATRIPTAN
RIVASTIGMINE vs ROACTEMRA
RIVASTIGMINE vs ROCURONIUM
RIVASTIGMINE vs ROFECOXIB